In silico assessment of binding affinities of three dementia-protective Human Leukocyte Antigen (HLA) alleles to nine human herpes virus antigens

James, 2019, The human leukocyte antigen (HLA) DRB1*13:02 allele protects against dementia in Continental Western Europe, J Neurol Neuromed, 4, 1, 10.29245/2572.942X/2019/5.1253 James, 2020, Tri-allelic human leukocyte antigen (HLA) protection against dementia, J Neurol Neuromed, 5, 12, 10.29245/2572.942X/2019/1.1261 James, 2018, Protective effect of human leukocyte antigen (HLA) allele DRB1* 13: 02 on age-related brain gray matter volume reduction in healthy women, EBioMedicine, 29, 31, 10.1016/j.ebiom.2018.02.005 James, 2018, The effects of human leukocyte antigen DRB1* 13 and apolipoprotein E on age-related variability of synchronous neural interactions in healthy women, EBioMedicine, 35, 288, 10.1016/j.ebiom.2018.08.026 James, 2019, Human leukocyte antigen as a key factor in preventing dementia and associated apolipoprotein E4 risk, Front Aging Neurosci, 10.3389/fnagi.2019.00082 James, 2018, Persistent antigens hypothesis: the human leukocyte antigen (HLA) connection, J Neurol Neuromed, 3, 27, 10.29245/2572.942X/2018/6.1235 Hov, 2011, Electrostatic modifications of the HLA-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis, Hepatology, 53, 1967, 10.1002/hep.24299 Davenport, 1995, Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain, PNAS, 92, 6567, 10.1073/pnas.92.14.6567 Maheshwari, 2015, Bacterial infection and Alzheimer’s disease: a meta-analysis, J Alzheimers Dis, 43, 957, 10.3233/JAD-140621 Mawanda, 2013, Can infections cause Alzheimer’s disease?, Epidemiol Rev, 35, 161, 10.1093/epirev/mxs007 Itzhaki, 2016, Microbes and Alzheimer’s disease, J Alzheimers Dis, 51, 979, 10.3233/JAD-160152 Itzhaki, 2018, Corroboration of a major role for herpes simplex virus type 1 in alzheimer’s disease, Front Aging Neurosci, 10, 10.3389/fnagi.2018.00324 Warren-Gash, 2019, Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis, Sci Rep, 18, 1 Carbone, 2013, Herpes virus in Alzheimer’s disease: relation to progression of the disease, Neurobiol Aging, 35, 122, 10.1016/j.neurobiolaging.2013.06.024 Chen, 2018, Herpes zoster and dementia: a nationwide population-based cohort study, J Clin Psychiat, 79, 10.4088/JCP.16m11312 Eimer, 2018, Alzheimer’s disease associated beta-amyloid is rapidly seeded by Herpesviridae to protect against brain infection, Neuron, 99, 56, 10.1016/j.neuron.2018.06.030 Readhead, 2018, Multiscale analysis of independent Alzheimer’s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus, Neuron, 99, 64, 10.1016/j.neuron.2018.05.023 Westman, 2017, Decreased HHV-6 IgG in Alzheimer’s disease, Front Neurol, 8, 40, 10.3389/fneur.2017.00040 Staras, 2006, Seroprevalence of cytomegalovirus infection in the United States, 1988–1994, Clin Infect Dis, 43, 1143, 10.1086/508173 Wald, 2007, Persistence in the population: epidemiology, transmission The Uniprot Consortium 2019 (https://www.uniprot.org/). Sturniolo, 1999, Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual class II matrices, Nat Biotechnol, 17, 555, 10.1038/9858 Rudensky, 1991, Sequence analysis of peptides bound to MHC class II molecules, Nature, 353, 622, 10.1038/353622a0 Chicz, 1992, Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size, Nature, 358, 764, 10.1038/358764a0 Castellino, 1997, Antigen presentation by MHC class II molecules: invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture, Hum Immunol, 54, 159, 10.1016/S0198-8859(97)00078-5 Rötzschke, 1997, Superactivation of an immune response triggered by oligomerized T cell epitopes, PNAS, 94, 14642, 10.1073/pnas.94.26.14642 White, 2014, Alzheimer’s associated –amyloid protein inhibits Influenza A virus and modulates viral interactions with phagocytes, PLoS One, 9, 10.1371/journal.pone.0101364 Soscia, 2010, The Alzheimer’s disease-associated amyloid beta-protein in an antimicrobial peptide, PLoS One, 5, e9505, 10.1371/journal.pone.0009505 Allnut, 2020, Human herpesvirus 6 detection in Alzheimer’s disease cases and controls across multiple cohorts, Neuron, 105, 1027, 10.1016/j.neuron.2019.12.031 Agostini, 2016, Lack of evidence for a role of HHV-6 in the pathogenesis of Alzheimer’s disease, J Alzheimer Dis, 49, 229, 10.3233/JAD-150464 Nichols, 2019, Global, regional, and national burden of Alzheimer’s disease and other dementias 1990–2016 a systematic analysis for the Global Burden of Disease Study 2016, Lancet Neurol, 88, 10.1016/S1474-4422(18)30403-4 Population Reference Bureau, 2016